Glenmark and Texmaco Rail Shares in Focus: Last Day for Dividend Eligibility Amid Corporate Updates
Today is the last day to purchase shares of Glenmark Pharmaceuticals and Texmaco Rail & Engineering to qualify for recently announced final dividends. Glenmark offers a 250% dividend (Rs 2.50 per share), while Texmaco Rail offers 75% (Rs 0.75 per share). The record date is set for September 12. Several other companies, including Aarti Pharmalabs, Alicon Castalloy, and Indraprastha Gas, have also declared dividends with the same record date. Separately, Texmaco Rail & Engineering announced the completion of its amalgamation with Texmaco West Rail Limited.

*this image is generated using AI for illustrative purposes only.
Investors are eyeing shares of Glenmark Pharmaceuticals and Texmaco Rail & Engineering as today marks the final opportunity to purchase shares and qualify for recently announced final dividends. The record date for shareholder eligibility is set for Friday, September 12, adding urgency to investment decisions.
Dividend Details
Glenmark Pharmaceuticals has declared a final dividend of 250% at Rs 2.50 per share, while Texmaco Rail & Engineering has announced a final dividend of 75% at Rs 0.75 per share. These attractive dividend yields are drawing attention from income-focused investors.
Other Companies Declaring Dividends
Several other companies have also declared final dividends with the same September 12 record date:
- Aarti Pharmalabs
- Alicon Castalloy
- DOMS Industries
- Empire Industries
- Indraprastha Gas
- Lux Industries
- The Phoenix Mills
Dividend amounts across these companies range from Rs 0.05 to Rs 25.00 per share, offering a variety of options for dividend-seeking investors.
Important Note for Investors
It's crucial for potential investors to note that shares purchased after today will not qualify for the dividend payouts on the record date. This deadline adds a sense of urgency for those looking to benefit from these dividend distributions.
Corporate Update: Texmaco Rail & Engineering
In addition to the dividend news, Texmaco Rail & Engineering has announced a significant corporate development. According to the company's latest filing:
- The Scheme of Amalgamation between Texmaco West Rail Limited (Transferor Company) and Texmaco Rail & Engineering Limited has become effective as of September 11.
- This follows the sanction of the scheme by the Hon'ble National Company Law Tribunal, Kolkata Bench.
- Texmaco West Rail Limited now stands amalgamated with Texmaco Rail & Engineering Limited.
This corporate restructuring could have implications for the company's future operations and financial performance, potentially influencing investor sentiment alongside the dividend announcement.
Market Implications
The combination of attractive dividends and corporate restructuring news, particularly for Texmaco Rail & Engineering, may lead to increased trading activity in these stocks. Investors are likely to weigh the immediate benefits of dividend payouts against longer-term implications of corporate actions when making their investment decisions.
As the market digests this information, it will be interesting to observe how these developments impact the share prices and trading volumes of the mentioned companies, especially Glenmark Pharmaceuticals and Texmaco Rail & Engineering, in the coming days.